Infusion device optimization by addressing root causes of the inflammatory response
通过解决炎症反应的根本原因来优化输注装置
基本信息
- 批准号:10612439
- 负责人:
- 金额:$ 55.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-20 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:AbdomenAchievementAddressAdvanced DevelopmentAffectAirAmericanArachidonic AcidsBiologicalBlood GlucoseBody Surface AreaButtocksCannulasCell CommunicationCell DegranulationCell LineCellsCharacteristicsCicatrixComplications of Diabetes MellitusConnective TissueCre-LoxPCresolCutaneousDataDermalDevicesDiabetes MellitusDiseaseDoseEnzyme InhibitionEpidemicEpidermisEventExcipientsExcisionFibrosisFormulationFutureGenesGlycosylated hemoglobin AGoalsHealth ExpendituresHumanHypoglycemiaIn VitroIncidenceInflammationInflammatoryInflammatory ResponseInfusion PumpsInfusion proceduresInjectionsInsulinInsulin-Dependent Diabetes MellitusKnowledgeLaboratoriesLeukocytesLifeLongevityMCL1 geneMacrophageMediatorMethodologyMolecularMusPathologyPathway interactionsPatientsPeptide HydrolasesPersonsPhagocytosisPharmaceutical PreparationsPharmaceutical SolutionsPhenolsPhenotypePhosphotransferasesPractice ManagementPreventive therapyProbabilityProteinsPublic HealthPublishingPuncture procedureReactionRecurrenceResearch Project GrantsRoleRotationSiteSkinSkin TissueSkin injurySterilitySubcutaneous TissueSystemTechnologyTestingTimeTissuesToxic effectTransgenic Miceabsorptionarmblood glucose regulationchemokineclinical efficacyclinically relevantcytokinecytotoxiccytotoxicitydiabetes managementdiabetes mellitus therapyeuglycemiafirst responderflexibilityglycemic controlimprovedin vivoinjection/infusioninnovationinsightinsulin mediatorsmanufacturemast cellmouse modelneutrophilnew technologynovelpediatric patientspharmacokinetics and pharmacodynamicsporcine modelpractice settingpre-clinicalpreservationpreventrecruitskin irritationskin organogenesissubcutaneoustissue injuryuptake
项目摘要
Significant progress in diabetes device technology has been realized over the past two decades. These novel
technologies improve glycemic control over daily injections thus reducing the probability of encountering
diabetic complications. Insulin infusion pump sets provide dosing flexibility and enhanced clinical efficacy in
terms of reducing HbA1c and severe hypoglycemic events. Despite these technological improvements in
insulin delivery systems, current best-practice set wear is typically limited to three days. Current challenges to
extending the lifespan of subcutaneous insulin administration sets and infusion pumps involve unreliable
insulin efficacy through the development of skin pathologies. Currently, all commercially available insulin
formulations contain insulin phenolic preservatives (IPP) known as excipients that are a double edge sword.
While they provide insulin protein stability, sterility and prolong insulin shelf life, our laboratory has recently
shown that these are cytotoxic, induce inflammation and secondary fibrosis. Subsequently, our data in murine
and porcine models demonstrated that proximate pre-infusion IPP removal significantly reduces infusion site
inflammation while maintaining protein functionality. Thus, the two major obstacles to increased infusion set
wear time are the chemotoxicity of the IPP and the transdermal cannula induced tissue injury, both of which
are inflammation driven. Mature mast cells (MC) reside in cutaneous tissue. Thus, MC are one of the first
responder in skin injury and are key contributors in orchestrating the inflammatory response once the skin is
breached. Therefore, our central hypothesis, supported by our published and preliminary data, is that
accumulative IPP and the transdermal injection and infusion devices contribute to local skin irritation due to
mast cell activation and subsequent leukocyte recruitment, thus initiating the inflammatory cascade. As MC
interact with macrophages (MQ) we further hypothesize that increased MC degranulation promotes M1
phenotype leading to phagocytosis insulin uptake/degradation by neutrophils & MQ and thus altering blood
glucose control. Therefore, our overall goals are, first, to determine how MC activation occurs, and, second,
the contribution to the resulting tissue reactions (inflammation and fibrotic cascades) while correlating IPP
concentration and composition for the duration of the infusion period. We will test our hypothesis in three
specific aims: 1) determine IPP induced MC activation and insulin degradation, 2) employ novel transgenic
mouse models (Cre/loxP) to determine the mechanisms and mediators of IPP and device MC induced
inflammation, and 3) preserve long-term tissue integrity during insulin infusion pump therapy in a pre-clinical
porcine model. Ultimately, the successful accomplishment of this proposal could result in transforming current
diabetes management practices that would achieve the goals of increasing the lifespan of insulin infusion
devices and most importantly, sustaining a tissue site available for future recurrent insulin administrations.
在过去的二十年中,糖尿病器械技术取得了重大进展。这些新颖
技术改善了每日注射的血糖控制,从而降低了遇到
糖尿病并发症胰岛素输注泵套件提供给药灵活性和增强的临床疗效,
降低HbA 1c和重度低血糖事件。尽管这些技术进步,
对于胰岛素输送系统,目前最佳实践的装置佩戴通常限于三天。目前受到的挑战
延长皮下胰岛素给药装置和输注泵的使用寿命涉及不可靠的
胰岛素的功效通过皮肤病理学的发展。目前,所有市售胰岛素
制剂含有胰岛素酚类防腐剂(IPP),称为赋形剂,是一把双刃剑。
虽然它们提供胰岛素蛋白质稳定性、无菌性和延长胰岛素保质期,但我们的实验室最近
显示这些是细胞毒性,诱导炎症和继发性纤维化。随后,我们在小鼠中的数据
和猪模型表明,在输注前去除IPP显著减少了输注部位
炎症,同时保持蛋白质功能。因此,增加输液器的两大障碍
磨损时间是IPP的化学毒性和经皮插管诱导的组织损伤,两者都
是由炎症驱动的成熟的肥大细胞(MC)存在于皮肤组织中。因此,MC是第一批
在皮肤损伤的反应,并在协调炎症反应的关键贡献者,一旦皮肤是
被攻破了因此,我们的中心假设,由我们公布的和初步的数据支持,是,
累积的IPP和经皮注射和输注装置会导致局部皮肤刺激,
肥大细胞活化和随后的白细胞募集,从而启动炎症级联反应。为MC
与巨噬细胞(MQ)相互作用,我们进一步假设MC脱颗粒增加促进M1
表型导致中性粒细胞吞噬胰岛素摄取/降解& MQ,从而改变血液
血糖控制因此,我们的总体目标是,首先,确定MC激活是如何发生的,其次,
导致组织反应(炎症和纤维化级联反应)的贡献,同时将IPP
在输注期的持续时间内的浓度和组成。我们将在三个方面来检验我们的假设
具体目的:1)确定IPP诱导的MC活化和胰岛素降解,2)使用新的转基因
小鼠模型(Cre/loxP),以确定IPP和器械MC诱导的机制和介质
炎症,和3)在临床前胰岛素输注泵治疗期间保持长期组织完整性
猪模型最终,该提案的成功完成可能会导致改变当前的
实现延长胰岛素输注寿命目标的糖尿病管理实践
设备,最重要的是,维持组织部位可用于未来的反复胰岛素给药。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ulrike Klueh其他文献
Ulrike Klueh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ulrike Klueh', 18)}}的其他基金
Infusion device optimization by addressing root causes of the inflammatory response
通过解决炎症反应的根本原因来优化输注装置
- 批准号:
10443241 - 财政年份:2022
- 资助金额:
$ 55.77万 - 项目类别:
相似海外基金
Collaborative Research: Using Adaptive Lessons to Enhance Motivation, Cognitive Engagement, And Achievement Through Equitable Classroom Preparation
协作研究:通过公平的课堂准备,利用适应性课程来增强动机、认知参与和成就
- 批准号:
2335802 - 财政年份:2024
- 资助金额:
$ 55.77万 - 项目类别:
Standard Grant
Collaborative Research: Using Adaptive Lessons to Enhance Motivation, Cognitive Engagement, And Achievement Through Equitable Classroom Preparation
协作研究:通过公平的课堂准备,利用适应性课程来增强动机、认知参与和成就
- 批准号:
2335801 - 财政年份:2024
- 资助金额:
$ 55.77万 - 项目类别:
Standard Grant
A Longitudinal Study of the Relationship between Participation in a Comprehensive Exercise Program and Academic Achievement
参加综合锻炼计划与学业成绩之间关系的纵向研究
- 批准号:
24K14615 - 财政年份:2024
- 资助金额:
$ 55.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Collaborative Research: Characterizing Best Practices of Instructors who Have Narrowed Performance Gaps in Undergraduate Student Achievement in Introductory STEM Courses
合作研究:缩小本科生 STEM 入门课程成绩差距的讲师的最佳实践
- 批准号:
2420369 - 财政年份:2024
- 资助金额:
$ 55.77万 - 项目类别:
Standard Grant
Collaborative Research: Using Adaptive Lessons to Enhance Motivation, Cognitive Engagement, And Achievement Through Equitable Classroom Preparation
协作研究:通过公平的课堂准备,利用适应性课程来增强动机、认知参与和成就
- 批准号:
2335800 - 财政年份:2024
- 资助金额:
$ 55.77万 - 项目类别:
Standard Grant
WTG: Diffusion of Research on Supporting Mathematics Achievement for Youth with Disabilities through Twitter Translational Visual Abstracts
WTG:通过 Twitter 翻译视觉摘要传播支持残疾青少年数学成就的研究
- 批准号:
2244734 - 财政年份:2023
- 资助金额:
$ 55.77万 - 项目类别:
Standard Grant
The Impact of Emotional Experiences of Pride on Long-Term Goal Achievement Behaviors in Elite Athletes
骄傲的情感体验对优秀运动员长期目标实现行为的影响
- 批准号:
23K16740 - 财政年份:2023
- 资助金额:
$ 55.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Meta-Analysis of the Instructional-Relational Model of Student Engagement and Math Achievement: A Moderation and Mediation Approach
学生参与度和数学成绩的教学关系模型的元分析:一种调节和中介方法
- 批准号:
2300738 - 财政年份:2023
- 资助金额:
$ 55.77万 - 项目类别:
Standard Grant
Improving maths achievement in children with speech, language, and communication needs through 'collaborative vocabulary teaching'
通过“协作词汇教学”提高有言语、语言和交流需求的儿童的数学成绩
- 批准号:
2890475 - 财政年份:2023
- 资助金额:
$ 55.77万 - 项目类别:
Studentship
HSI Institutional Transformation Project: Retention and Achievement for Introductory STEM English Learners (RAISE)
HSI 机构转型项目:STEM 英语入门学习者的保留和成就 (RAISE)
- 批准号:
2225178 - 财政年份:2023
- 资助金额:
$ 55.77万 - 项目类别:
Continuing Grant